TABLE 6.
Main findings in non‐CNS cancer survivors compared to healthy controls | Summary of interactions in non‐CNS cancer survivors between main findings | |||
---|---|---|---|---|
FA superior cerebellar peduncle | Chronic symptomatology (VHNSS, GSS, neurotoxicity) | BRIEF neurocognitive functioning (↑ BRIEF scores = ↑ impairment) | ||
Centralized inflammation caudate | ↑ | X | X | X |
Centralized inflammation temporal | ↑ | X | + Corr w/: VHNSS; neurotoxicity | X |
Centralized inflammation occipital | ↑ | X | X | − Corr w/: emotion control |
Centralized inflammation CSF 3rd ventricle | X | X | X | X |
Centralized inflammation CSF 4th ventricle | ↓ | X | + Corr w/: sleep disturbance | + Corr w/: shift |
Peripheral pro‐inflammatory cytokines | X | X | ||
Peripheral anti‐inflammatory cytokines | X | X | ||
Peripheral blood C‐Reactive protein | X | −Corr (↓FA = ↑CRP) | ||
White matter FA superior cerebellar peduncle | ↓ | −Corr w/: VHNSS; GSS; neurotoxicity | X | |
White matter FA all other ROIs | X | |||
MRI right hemisphere precentral cortical thickness | ↓ | X | X | X |
Note: centralized inflammation = [11C]‐PBR28 SUVR data; peripheral cytokines = blood serum assay data.
Abbreviations: CSF, cerebrospinal fluid; FA, fractional anisotropy from DTI data; GSS, VHNSS General Symptom Survey; VHNSS, Vanderbilt Head and Neck Symptom Survey Version 2.0 total score.